美國研究綜述-Crowdstrike、FactSet、Rivian

路透中文

07/03

美國研究綜述-Crowdstrike、FactSet、<a href="https://laohu8.com/S/RIVN">Rivian</a>

路透7月3日 - 周五，華爾街證券分析師上調了包括Crowdstrike、Factset和Rivian在內的幾家美國上市公司評級及目標股價。

要點

* Crowdstrike CRWD.O：Canaccord Genuity將目標價從168.75美元上調至185美元

* Factset FDS.N：傑富瑞將目標價從225美元上調至253美元

* Rivian RIVN.O：摩根大通將目標價從9美元上調至15美元

以下是路透周五報導的針對美國公司的研究行動摘要。股票條目按字母順序排列。

* 星座品牌（Constellation Brands） STZ.N：滙豐將目標價從190美元上調至192美元

* Crowdstrike CRWD.O：Canaccord Genuity將目標價從168.75美元上調至185美元

* Factset FDS.N：傑富瑞將目標價從225美元上調至253美元

* 通用磨坊公司 GIS.N：滙豐將目標價從44美元下調至41美元

* Procept Biorobotics Corp PRCT.O：Truist Securities將評級從「買入」下調至「持有」

* Procept Biorobotics Corp PRCT.O：Truist證券將目標價從30美元下調至25美元

* Rivian RIVN.O：摩根大通將目標價從9美元上調至15美元

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2648651121"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2648651121\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2648651121?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-07-03 15:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2648651121","market":"us","top_or_hot":-1,"title":"美國研究綜述-Crowdstrike、FactSet、Rivian","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>美國研究綜述-Crowdstrike、FactSet、<a href=\"https://laohu8.com/S/RIVN\">Rivian</a></title></head><body><p><span>路透7月3日</span><span> - </span>周五，華爾街證券分析師上調了包括Crowdstrike、Factset和Rivian在內的幾家美國上市公司評級及目標股價。 </p><p>要點 </p><table><tbody><tr><td><p><span> * Crowdstrike <span><a href=\"https://laohu8.com/S/CRWD\">CRWD</a>.O</span>：<a href=\"https://laohu8.com/S/CCORF\">Canaccord Genuity</a>將目標價從168.75美元上調至185美元</span></p></td></tr><tr><td><p><span> * Factset <span>FDS.N</span>：<a href=\"https://laohu8.com/S/JEF\">傑富瑞</a>將目標價從225美元上調至253美元</span></p></td></tr><tr><td><p><span> * Rivian <span>RIVN.O</span>：<a href=\"https://laohu8.com/S/JPM\">摩根大通</a>將目標價從9美元上調至15美元</span></p></td></tr></tbody></table><p>以下是路透周五報導的針對美國公司的研究行動摘要。股票條目按字母順序排列。  </p><table><tbody><tr><td><p><span> * <a href=\"https://laohu8.com/S/STZ\">星座品牌</a>（<a href=\"https://laohu8.com/S/CEG\">Constellation</a> Brands） <span>STZ.N</span>：<a href=\"https://laohu8.com/S/HSBC\">滙豐</a>將目標價從190美元上調至192美元</span></p></td></tr><tr><td><p><span> * Crowdstrike <span>CRWD.O</span>：Canaccord Genuity將目標價從168.75美元上調至185美元</span></p></td></tr><tr><td><p><span> * Factset <span>FDS.N</span>：傑富瑞將目標價從225美元上調至253美元</span></p></td></tr><tr><td><p><span> * <a href=\"https://laohu8.com/S/GIS\">通用磨坊</a>公司 <span>GIS.N</span>：<a href=\"https://laohu8.com/S/00005\">滙豐</a>將目標價從44美元下調至41美元</span></p></td></tr><tr><td><p><span> * Procept Biorobotics Corp <span>PRCT.O</span>：Truist Securities將評級從「買入」下調至「持有」</span></p></td></tr><tr><td><p><span> * Procept Biorobotics Corp <span>PRCT.O</span>：Truist證券將目標價從30美元下調至25美元</span></p></td></tr><tr><td><p><span> * Rivian <span>RIVN.O</span>：摩根大通將目標價從9美元上調至15美元</span></p></td></tr></tbody></table></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美國研究綜述-Crowdstrike、FactSet、Rivian</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美國研究綜述-Crowdstrike、FactSet、Rivian\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time smaller\">2026-07-03 15:52</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>美國研究綜述-Crowdstrike、FactSet、<a href=\"https://laohu8.com/S/RIVN\">Rivian</a></title></head><body><p><span>路透7月3日</span><span> - </span>周五，華爾街證券分析師上調了包括Crowdstrike、Factset和Rivian在內的幾家美國上市公司評級及目標股價。 </p><p>要點 </p><table><tbody><tr><td><p><span> * Crowdstrike <span><a href=\"https://laohu8.com/S/CRWD\">CRWD</a>.O</span>：<a href=\"https://laohu8.com/S/CCORF\">Canaccord Genuity</a>將目標價從168.75美元上調至185美元</span></p></td></tr><tr><td><p><span> * Factset <span>FDS.N</span>：<a href=\"https://laohu8.com/S/JEF\">傑富瑞</a>將目標價從225美元上調至253美元</span></p></td></tr><tr><td><p><span> * Rivian <span>RIVN.O</span>：<a href=\"https://laohu8.com/S/JPM\">摩根大通</a>將目標價從9美元上調至15美元</span></p></td></tr></tbody></table><p>以下是路透周五報導的針對美國公司的研究行動摘要。股票條目按字母順序排列。  </p><table><tbody><tr><td><p><span> * <a href=\"https://laohu8.com/S/STZ\">星座品牌</a>（<a href=\"https://laohu8.com/S/CEG\">Constellation</a> Brands） <span>STZ.N</span>：<a href=\"https://laohu8.com/S/HSBC\">滙豐</a>將目標價從190美元上調至192美元</span></p></td></tr><tr><td><p><span> * Crowdstrike <span>CRWD.O</span>：Canaccord Genuity將目標價從168.75美元上調至185美元</span></p></td></tr><tr><td><p><span> * Factset <span>FDS.N</span>：傑富瑞將目標價從225美元上調至253美元</span></p></td></tr><tr><td><p><span> * <a href=\"https://laohu8.com/S/GIS\">通用磨坊</a>公司 <span>GIS.N</span>：<a href=\"https://laohu8.com/S/00005\">滙豐</a>將目標價從44美元下調至41美元</span></p></td></tr><tr><td><p><span> * Procept Biorobotics Corp <span>PRCT.O</span>：Truist Securities將評級從「買入」下調至「持有」</span></p></td></tr><tr><td><p><span> * Procept Biorobotics Corp <span>PRCT.O</span>：Truist證券將目標價從30美元下調至25美元</span></p></td></tr><tr><td><p><span> * Rivian <span>RIVN.O</span>：摩根大通將目標價從9美元上調至15美元</span></p></td></tr></tbody></table></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4555","symbol_name":"新能源車","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nL4T4350HA:1","article_id":"2648651121","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2648651121","pubTimestamp":1783065127,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"美國研究綜述-Crowdstrike、FactSet、Rivian路透7月3日-周五，華爾街證券分析師上調了包括Crowdstrike、Factset和Rivian在內的幾家美國上市公司評級及目標股價。要點* CrowdstrikeCRWD.O：Canaccord Genuity將目標價從168.75美元上調至185美元* FactsetFDS.N：傑富瑞將目標價從225美元上調至253美元* RivianRIVN.O：摩根大通將目標價從9美元上調至15美元以下是路透周五報導的針對美國公司的研究行動摘要。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4555":"新能源车","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","LU2272731782.SGD":"Allianz Global Intelligent Cities AM Dis H2-SGD","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","CRWL":"2倍做多CRWD ETF-GraniteShares","LU1917777945.USD":"安联专题基金Cl AT Acc","BK4547":"WSB热门概念","LU0081259029.USD":"UBS (LUX) EQUITY FUND - TECH OPPORTUNITY \"P\" (USD) ACC","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","PRCT":"PROCEPT BioRobotics","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","LU2552382215.SGD":"WELLINGTON US BRAND POWER \"A\" (SGDHDG) ACC","LU1548497426.USD":"安联环球人工智能AT Acc","LU1989763690.USD":"东方汇理世代食品基金A2 Acc","BK4596":"哈里斯概念","BK4504":"桥水持仓","STZ":"星座品牌","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","BK4588":"碎股","IE00B19Z9Z06.USD":"Legg Mason ClearBridge - US Aggressive Growth A Acc USD","LU2433249047.HKD":"THEMATICS META \"R/A\" (HKD) ACC","LU2286300806.USD":"Allianz Cyber Security AT Acc USD","LU2552382132.HKD":"WELLINGTON US BRAND POWER \"A\" (HKD) ACC","LU2125909759.SGD":"Natixis Thematics Safety H-R/A SGD","LU2211815571.USD":"ALLIANZ POSITIVE CHANGE \"AT\" (USD) ACC","LU2125909916.SGD":"Natixis Thematics Safety R/A SGD","RIVN":"Rivian Automotive, Inc.","LU1992135399.USD":"Allianz Global Intelligent Cities AT Acc USD","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","BK4112":"金融交易所和数据","RVNL":"2倍做多RIVN ETF-GraniteShares","BK4598":"佩洛西持仓","BK4551":"寇图资本持仓","BK4169":"酿酒商与葡萄酒商","LU1923622291.USD":"Natixis Thematics Safety R/A USD","CRWD":"CrowdStrike Holdings, Inc.","BK4097":"系统软件","BK4532":"文艺复兴科技持仓","FDS":"辉盛研究系统","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","LU1951198990.SGD":"Natixis Thematics AI & Robotics Fund H-R/A SGD-H","BK4543":"AI","LU1951200564.SGD":"Natixis Thematics AI & Robotics Fund R/A SGD","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","BK4567":"ESG概念","GIS":"通用磨坊","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD"},"translate_title":"U.S. Research Roundup-CrowdStrike, FactSet, Rivian","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRWD":0.9,"STZ":0.9,"CRWL":0.6,"FDS":0.9,"GIS":0.9,"RIVN":0.9,"PRCT":0.9,"RVNL":0.6},"content_text":"美國研究綜述-Crowdstrike、FactSet、Rivian路透7月3日 - 周五，華爾街證券分析師上調了包括Crowdstrike、Factset和Rivian在內的幾家美國上市公司評級及目標股價。 要點  * Crowdstrike CRWD.O：Canaccord Genuity將目標價從168.75美元上調至185美元 * Factset FDS.N：傑富瑞將目標價從225美元上調至253美元 * Rivian RIVN.O：摩根大通將目標價從9美元上調至15美元以下是路透周五報導的針對美國公司的研究行動摘要。股票條目按字母順序排列。   * 星座品牌（Constellation Brands） STZ.N：滙豐將目標價從190美元上調至192美元 * Crowdstrike CRWD.O：Canaccord Genuity將目標價從168.75美元上調至185美元 * Factset FDS.N：傑富瑞將目標價從225美元上調至253美元 * 通用磨坊公司 GIS.N：滙豐將目標價從44美元下調至41美元 * Procept Biorobotics Corp PRCT.O：Truist Securities將評級從「買入」下調至「持有」 * Procept Biorobotics Corp PRCT.O：Truist證券將目標價從30美元下調至25美元 * Rivian RIVN.O：摩根大通將目標價從9美元上調至15美元","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}